|Date:||Tuesday, November 15, 2016|
|Time:||3:45 pm Eastern Time / 12:45 pm Pacific Time|
|Location:||New York, NY|
CONTACT: Investors: Andrew McDonaldFounding Partner, LifeSci Advisors LLC646-597-6987 | Andrew@lifesciadvisors.com
Despite a win in court over its patents and a deal with activist investors, Depomed shares dropped after it gave a reduced guidance for 2016 revenues.
Shares of Omeros fell almost 10% after analysts' downgraded the biotech.